Core Viewpoint - Longevity Health Holdings, Inc. has appointed Ram Ajjarapu as Chairman and Chief Executive Officer, effective March 16, 2026, aiming to advance its growth strategy through acquisitions as a public company [1][2]. Leadership Transition - Ram Ajjarapu brings a strong track record in scaling businesses and executing value-creating transactions, with a commitment to pursue disciplined, value-accretive acquisitions that enhance operations and profitability [2][3]. - Rajiv Shukla, the outgoing Chairman and CEO, will serve as an advisor to ensure continuity during the leadership transition and remains a significant shareholder [3]. Strategic Investment - Ajjarapu made a strategic investment in Longevity through a private placement that closed on March 16, 2026, acquiring a significant equity position that aligns his interests with those of the stockholders [3]. Company Overview - Longevity Health Holdings, Inc. is a bio-aesthetics company focused on longevity and healthy aging, offering two cosmetic product lines: Elevai Exosomes™ and Carmell Secretome™, which support skin and hair health [5]. - The company sells its products in the United States through business-to-business, direct-to-consumer, and distributor sales channels [5]. Leadership Background - Ram Ajjarapu, age 57, has extensive experience in technology and business management, having served as CEO in various companies and founded multiple successful ventures [4].